In addition, CLL cells secreted the danger-associated molecular pattern (DAMP) HMGB1 (Fig. 6f) and ATP to the supernatants upon 3AC treatment in a dose-dependent manner (Fig. 6g), which also contributes to the activation of adjacent immune cells. Here, HMGB1 is linked to B-cell chronic lymphocytic leukemia.